Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 408601 - 408620 out of 563565 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Poland | (L01EX03) pazopanib (adm: O) | Pazopanib Stada, tabl. powl., 400 mg | 60 szt., 400 mg , 60 tabl. | Wholesale price with vat |
$0-0 |
$0-0 |
n/a | STADAArzneimittelAG |
| Poland | (L01EX03) pazopanib (adm: O) | Pazopanib Viatris, tabl. powl., 200 mg | 30 szt., 200 mg , 30 tabl. | Wholesale price with vat |
$0-0 |
$0-0 |
n/a | ViatrisLtd |
| Poland | (L01EX03) pazopanib (adm: O) | Pazopanib Viatris, tabl. powl., 400 mg | 60 szt., 400 mg , 60 tabl. | Wholesale price with vat |
$0-0 |
$0-0 |
n/a | ViatrisLtd |
| Poland | (L01EX03) pazopanib (adm: O) | Pazopanib Zentiva, tabl. powl., 200 mg | 30 szt., 200 mg , 30 tabl. w butelce | Wholesale price with vat |
$0-0 |
$0-0 |
n/a | Zentiva,k.s. |
| Poland | (L01EX03) pazopanib (adm: O) | Pazopanib Zentiva, tabl. powl., 200 mg | 90 szt., 200 mg , 90 tabl. w butelce | Wholesale price with vat |
$0-0 |
$0-0 |
n/a | Zentiva,k.s. |
| Poland | (L01EX03) pazopanib (adm: O) | Pazopanib Zentiva, tabl. powl., 400 mg | 30 szt., 400 mg , 30 tabl. w butelce | Wholesale price with vat |
$0-0 |
$0-0 |
n/a | Zentiva,k.s. |
| Poland | (L01EX03) pazopanib (adm: O) | Pazopanib Zentiva, tabl. powl., 400 mg | 60 szt., 400 mg , 60 tabl. w butelce | Wholesale price with vat |
$0-0 |
$0-0 |
n/a | Zentiva,k.s. |
| Poland | (L01FF01) nivolumab (adm: P) | Opdivo, koncentrat do sporządzania roztworu do infuzji, 10 mg/ml | 1 fiol. po 4 ml, 10 mg/ml , 1 fiol. 4 ml | Wholesale price with vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Mesothelioma;Colorectal Neoplasms | Bristol-MyersSquibbPharmaEEIG |
| Poland | (L01FF01) nivolumab (adm: P) | Opdivo, koncentrat do sporządzania roztworu do infuzji, 10 mg/ml | 1 fiol. po 10 ml, 10 mg/ml , 1 fiol. 10 ml | Wholesale price with vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Mesothelioma;Colorectal Neoplasms | Bristol-MyersSquibbPharmaEEIG |
| Poland | (L01FF12) serplulimab | Hetronifly, koncentrat do sporządzania roztworu do infuzji, 10 mg/ml | 1 fiol. 10 ml, 10 mg/ml , 1 fiol. 10 ml | Wholesale price with vat |
$0-0 |
$0-0 |
Small Cell Lung Carcinoma | AccordHealthcareS.L.U. |
| Poland | (L01FX04) ipilimumab (adm: P) | Yervoy, koncentrat do sporządzania roztworu do infuzji (jałowy koncentrat), 5 mg/ml | 1 fiol. po 10 ml, 5 mg/ml , 1 fiol. 10 ml | Wholesale price with vat |
$0-0 |
$0-0 |
Melanoma;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Mesothelioma, Malignant;Colorectal Neoplasms | Bristol-MyersSquibbPharmaEEIG |
| Poland | (L01FX04) ipilimumab (adm: P) | Yervoy, koncentrat do sporządzania roztworu do infuzji (jałowy koncentrat), 5 mg/ml | 1 fiol. po 40 ml, 5 mg/ml , 1 fiol. 40 ml | Wholesale price with vat |
$0-0 |
$0-0 |
Melanoma;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Mesothelioma, Malignant;Colorectal Neoplasms | Bristol-MyersSquibbPharmaEEIG |
| Poland | (L01FX07) blinatumomab (adm: P) | Blincyto, proszek do przygotowania koncentratu do sporządzania roztworu do infuzji, 38,5 µg | 1 fiol. proszku + 1 fiol. 10 ml roztworu stabilizującego, 38,5 mcg , 1 fiol. 10 ml roztworu stabilizującego | Wholesale price with vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma | AmgenEuropeB.V. |
| Poland | (L01FX08) elotuzumab (adm: P) | Empliciti, proszek do sporządzania koncentratu roztworu do infuzji, 300 mg | 1 fiol., 300 mg , 1 fiol. 300 mg proszku | Wholesale price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | Bristol-MyersSquibbPharmaEEIG |
| Poland | (L01FX08) elotuzumab (adm: P) | Empliciti, proszek do sporządzania koncentratu roztworu do infuzji, 400 mg | 1 fiol., 400 mg , 1 fiol. 400 mg proszku | Wholesale price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | Bristol-MyersSquibbPharmaEEIG |
| Poland | (L01FX18) amivantamab | Rybrevant, koncentrat do sporządzania roztworu do infuzji, 350 mg | 1 fiol. 7 ml, 350 mg , 1 fiol. 7 ml | Wholesale price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | Janssen-CilagInternationalN.V. |
| Poland | (L01FX18) amivantamab | Rybrevant, roztwór do wstrzykiwań, 1600 mg | 1 fiol. 10 ml, 1600 mg , 1 fiol. 10 ml | Wholesale price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | Janssen-CilagInternationalN.V. |
| Poland | (L01FX18) amivantamab | Rybrevant, roztwór do wstrzykiwań, 2240 mg | 1 fiol. 14 ml, 2240 mg , 1 fiol. 14 ml | Wholesale price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | Janssen-CilagInternationalN.V. |
| Poland | (L01XL08) lisocabtagene maraleucel | Breyanzi, dyspersja do infuzji, 1,1–70 x 10^6 komórek/ml / 1,1–70 x 10^6 komórek/ml | 1 zestaw, 1,1–70 × 106 komórek/ml / 1,1–70 × 10 6 komórek/ml , 1 zestaw | Wholesale price with vat |
$0-0 |
$0-0 |
Lymphoma, Large B-Cell, Diffuse;Lymphoma, Follicular;Mediastinal Neoplasms | Bristol-MyersSquibbPharmaEEIG |
| Poland | (L04AC05) ustekinumab (adm: P) | Steqeyma, koncentrat do sporządzania roztworu do infuzji, 130 mg | 1 fiolka (30ml), 130 mg , 1 fiol. 26 ml | Wholesale price with vat |
$0-0 |
$0-0 |
Psoriasis;Arthritis, Psoriatic;Crohn Disease | CelltrionHealthcareHungaryKft. |
Pages
